F. de Vassal

ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA

G Mathé, Jeanne Amiel, L Schwarzenberg et al. · The Lancet · 1969 · 613 citations

Life Sciences, Hematology, Immunology +8

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

G Mathé, L Schwarzenberg, P Pouillart et al. · Cancer · 1974 · 118 citations · Full text

Medicine, Oncology, Pharmacology +13

NEW ANTIGENS IN HUMAN LEUKÆMIC CELLS, AND ANTIBODY IN THE SERUM OF LEUKÆMIC PATIENTS

J F Doré, L Marholev, H Colas De La Noue et al. · The Lancet · 1967 · 61 citations

Life Sciences, Hematology, Immunology +6

Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.

G Mathé, J. L. Misset, F. de Vassal et al. · PubMed · 1978 · 52 citations

Medicine, Oncology, Pharmacology +17

Hydroxyurea, Leucopheresis, and Splenectomy in Chronic Myeloid Leukaemia at the Problastic Phase

L Schwarzenberg, G Mathé, P Pouillart et al. · BMJ · 1973 · 36 citations · Full text

Medicine, Hematology, Surgery +16